FDA Device Recalls

Recalls /

#162525

Product

ADVIA Centaur HBc IgM

FDA product code
LOMTest, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)
Device class
Class 2
Medical specialty
Microbiology
PMA numbers
P030040
Affected lot / code info
ADVIA Centaur¿ HBc IgM; test, hepatitis b (b core, be antigen, be antibody, b core igm); SMN 10308978   Lot codes: ADVIA Centaur aHBcM Lot # 02437164 14331164 20876164 29394164 81764164 93146164 26976167 39604167 44125167 56754167 67635167 77328167 01396170 07110170 21484170 67103170 86117170 92364170 31751171 33726171 41538171  ***Added 9/11/20*** 10308978  ***Added 11/2/20*** 62572190  ***Added 3/11/21*** 39927194

Why it was recalled

Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirolimus, ADVIA Centaur FOL, ADVIA Centaur aHBcM and the following IMMULITE assays, 3gAllergy Specific IgE, anti-HBc, BR-MA (CA15-3), CEA, Folic Acid, Gastrin, OM-MA (CA125), Thyroglobulin, and Vitamin B12, and these assays are susceptible to interference from biotin.

Root cause (FDA determination)

Error in labeling

Action the firm took

Siemens Healthcare Diagnostics issued a recall in March 2017 for products with incorrect units for biotin in the Instructions for Use. After further investigation, recalling firm determined that more Siemens products also had missing or incorrect information in the IFUs for which two recalls were initiated, and Amended Corrections and Removals Reports were submitted to the FDA

Recalling firm

Firm
Siemens Healthcare Diagnostics, Inc.
Address
511 Benedict Ave, Tarrytown, New York 10591-5005

Distribution

Distribution pattern
Nationwide and Canada, Mexico, and Thailand

Timeline

Recall initiated
2018-01-02
Posted by FDA
2018-05-04
Terminated
2023-02-10
Status

Source: openFDA Device Recall endpoint. Recall record ID #162525. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.